Ionis Pharmaceuticals Company Profile (NASDAQ:IONS)

Analyst Ratings

Consensus Ratings for Ionis Pharmaceuticals (NASDAQ:IONS) (?)
Ratings Breakdown: 1 Sell Rating(s), 6 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Hold (Score: 2.20)
Consensus Price Target: $31.63 (11.43% upside)

Analysts' Ratings History for Ionis Pharmaceuticals (NASDAQ:IONS)
Show:
DateFirmActionRatingPrice TargetActions
7/18/2016Leerink SwannReiterated RatingMarket Perform$39.00 -> $26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/15/2016Jefferies GroupReiterated RatingUnderperform$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/15/2016Piper Jaffray Cos.Reiterated RatingOverweight$35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/14/2016Needham & Company LLCReiterated RatingBuy$55.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/14/2016Cowen and CompanyReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/8/2016BMO Capital MarketsReiterated RatingMarket Perform$26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/29/2016JPMorgan Chase & Co.Reiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/27/2016Barclays PLCLower Price TargetEqual Weight$42.00 -> $26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2016Wells Fargo & Co.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/22/2016Goldman Sachs Group Inc.Lower Price Target$65.00 -> $48.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/22/2015Deutsche Bank AGSet Price TargetBuy$78.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/17/2015Janney Montgomery ScottInitiated CoverageNeutral -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/2/2015Stifel NicolausDowngradeBuy -> Hold$66.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/2/2015Brean CapitalDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/9/2014LaidlawBoost Price Target$65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/26/2014 forward)

Earnings

Earnings History for Ionis Pharmaceuticals (NASDAQ:IONS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/2/2016        
5/4/2016Q116($0.50)($0.52)$36.21 million$36.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/25/2016Q415($0.47)($0.59)$49.32 million$51.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/9/2015Q315($0.31)($0.30)$52.93 million$49.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2015Q215$0.29$0.29$114.93 million$120.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2015Q115($0.19)($0.14)$52.74 million$62.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/27/2015Q414$0.12$0.25$74.58 million$84.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2014Q314($0.20)($0.23)$45.79 million$44.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2014Q214($0.12)($0.10)$45.60 million$57.08 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2014Q114($0.23)($0.27)$35.12 million$28.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/28/2014Q413($0.17)($0.21)$34.20 million$42.25 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2013Q313($0.27)($0.21)$19.82 million$23.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2013Q2 2013($0.21)($0.09)$26.76 million$38.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2013Q1 2013($0.02)($0.02)$45.24 million$43.36 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/28/2013Q4 2012($0.23)($0.03)$15.78 million$19.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2012Q312($0.26)($0.37)$23.11 million$11.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2012($0.08)($0.01)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2012($0.28)($0.24)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/29/2012($0.13)($0.20)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2011($0.20)($0.27)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2011($0.22)($0.18)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2011($0.19)($0.20)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/28/2011($0.22)($0.14)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Ionis Pharmaceuticals (NASDAQ:IONS)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20162($0.50)($0.45)($0.48)
Q3 20161($0.51)($0.51)($0.51)
Q4 20161($0.44)($0.44)($0.44)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Ionis Pharmaceuticals (NASDAQ:IONS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Ionis Pharmaceuticals (NASDAQ:IONS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/31/2016Frederick T MutoDirectorSell12,500$22.31$278,875.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/6/2016Patrick R O'neilSVPSell1,000$45.00$45,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/6/2016Stanley T CrookeCEOSell11,000$46.13$507,430.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/31/2016Stanley T CrookeCEOSell11,000$40.74$448,140.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/23/2016Patrick R O'neilSVPSell1,000$45.40$45,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/19/2016B Lynne ParshallCOOSell5,192$41.46$215,260.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/19/2016C Frank BennettSVPSell2,110$41.46$87,480.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/19/2016Elizabeth L. HougenCFOSell1,899$41.46$78,732.54View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/19/2016Sarah BoyceinsiderSell872$41.46$36,153.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/19/2016Stanley T. CrookeCEOSell13,401$41.46$555,605.46View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/5/2016Stanley T. CrookeCEOSell5,500$62.10$341,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/4/2016B Lynne ParshallCOOSell809$61.05$49,389.45View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/4/2016Brett P. MoniaSVPSell127$61.00$7,747.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/4/2016Stanley T. CrookeCEOSell11,000$61.05$671,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/16/2015C Frank BennettSVPSell7,909$57.41$454,055.69View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2015Patrick R. O'neilSVPSell1,000$61.50$61,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/11/2015Joseph Klein IIIDirectorSell6,875$64.18$441,237.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/10/2015C Frank BennettSVPSell5,000$64.00$320,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/6/2015C Frank BennettSVPSell5,000$56.00$280,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2015Patrick R. O'neilSVPSell1,000$51.95$51,950.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/23/2015Stanley T. CrookeCEOSell44,000$43.85$1,929,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/2/2015B Lynne ParshallCOOSell12,436$40.75$506,767.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/6/2015B Lynne ParshallCOOSell6,218$57.01$354,488.18View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/6/2015Stanley T CrookeCEOSell5,000$57.01$285,050.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2015B Lynne ParshallCOOSell6,218$57.56$357,908.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2015Stanley T CrookeCEOSell6,175$57.56$355,433.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/8/2015Brett P MoniaSVPSell7,600$66.22$503,272.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/7/2015B Lynne ParshallCOOSell5,565$63.07$350,984.55View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/7/2015Stanley T CrookeCEOSell22,377$63.07$1,411,317.39View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/24/2015C Frank BennettSVPSell15,000$70.61$1,059,150.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/19/2015Elizabeth L HougenCFOSell10,000$73.33$733,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/19/2015Patrick R O'neilSVPSell30,525$74.85$2,284,796.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2015Joseph H WenderDirectorSell7,000$65.97$461,790.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/27/2015Stanley T CrookeCEOSell11,000$72.93$802,230.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/16/2015B Lynne ParshallCOOSell4,093$67.96$278,160.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/16/2015Elizabeth L HougenCFOSell1,291$67.96$87,736.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/16/2015Richard S GearySVPSell1,543$67.96$104,862.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/16/2015Stanley T CrookeCEOSell9,054$67.96$615,309.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/9/2015Stanley T CrookeCEOSell11,000$73.57$809,270.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/7/2015Stanley T CrookeCEOSell22,000$67.04$1,474,880.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2015B Lynne ParshallCOOSell11,200$62.12$695,744.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2015Patrick R O'neilSVPSell1,500$62.12$93,180.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2014Patrick R O'neilSVPSell1,500$51.21$76,815.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014Patrick R O'neilSVPSell1,500$46.17$69,255.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/30/2014B Lynne ParshallCOOSell11,071$45.12$499,523.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/23/2014Stanley T CrookeCEOSell14,600$42.22$616,412.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/3/2014Stanley T CrookeCEOSell36,000$38.52$1,386,720.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2014Patrick R O'neilSVPSell1,500$38.04$57,060.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2014Stanley T CrookeCEOSell20,000$37.91$758,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2014C Frank BennettSVPSell5,000$40.53$202,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2014Stanley T CrookeCEOSell15,500$35.45$549,475.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2014Patrick R O'neilSVPSell1,500$35.00$52,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2014Stanley T CrookeCEOSell16,000$30.53$488,480.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/31/2014Brett P MoniaSVPSell79$31.50$2,488.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2014Patrick R O'neilSVPSell1,500$35.33$52,995.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2014Stanley T CrookeCEOSell17,500$35.57$622,475.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/23/2014C Frank BennettSVPSell11,200$36.78$411,936.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/19/2014Stanley T CrookeCEOSell11,000$35.10$386,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2014Stanley T CrookeCEOSell11,000$33.46$368,060.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/2/2014Frederick T MutoDirectorSell10,000$28.59$285,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/2/2014Stanley CrookeCEOSell8,800$43.65$384,120.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/30/2014B Lynne ParshallCOOSell89,510$49.49$4,429,849.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/24/2014Joseph Klein IIIDirectorSell10,313$48.66$501,830.58View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/22/2014Joseph WenderDirectorSell10,000$50.98$509,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/22/2014Richard GearySVPSell22,200$50.05$1,111,110.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/16/2014B Lynne ParshallCOOSell1,641$47.08$77,258.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/16/2014Stanley CrookeCEOSell3,527$47.08$166,051.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/8/2014Richard GearySVPSell15,000$40.45$606,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/8/2014Stanley CrookeCEOSell12,500$40.05$500,625.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2014Stanley CrookeCEOSell31,500$39.35$1,239,525.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/26/2013B Lynne ParshallCOOSell37,811$40.91$1,546,848.01View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/24/2013B Lynne ParshallCOOSell70,000$41.49$2,904,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/20/2013Joseph WenderDirectorSell19,731$39.58$780,952.98View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/5/2013C Frank BennettSVPSell10,000$39.92$399,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/26/2013Joseph WenderDirectorSell10,000$36.63$366,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/20/2013B Lynne ParshallCOOSell90,000$35.43$3,188,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/20/2013Brett MoniaSVPSell68,281$34.21$2,335,893.01View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/20/2013Stanley CrookeCEOSell58,740$35.19$2,067,060.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/19/2013C Frank BennettSVPSell10,000$35.02$350,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/11/2013B Lynne ParshallCOOSell63,505$31.04$1,971,195.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/9/2013C Frank BennettSVPSell10,000$30.23$302,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2013Patrick R O'neilSVPSell2,500$27.09$67,725.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2013Brett MoniaSVPSell2,909$25.58$74,412.22View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/9/2013Joseph Klein IIIDirectorSell18,750$28.22$529,125.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/23/2013Stanley T CrookeCOOSell11,500$30.00$345,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/22/2013Stanley T CrookeCEOSell62,200$30.50$1,897,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/17/2013Stanley T CrookeCEOSell49,300$33.12$1,632,816.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/12/2013Stanley T CrookeCEOSell90,000$31.75$2,857,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/11/2013Richard S GearySVPSell9,000$31.90$287,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/9/2013Richard S GearySVPSell66,163$30.03$1,986,874.89View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/9/2013Stanley T CrookeCEOSell109,172$26.69$2,913,800.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/3/2013Richard S GearySVPSell5,000$29.02$145,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2013Stanley T CrookeCEOSell50,683$27.65$1,401,384.95View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/26/2013Stanley T CrookeCEOSell90,000$26.73$2,405,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/25/2013Richard S GearySVPSell47,049$26.20$1,232,683.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/20/2013Joseph H WenderDirectorSell5,447$20.93$114,005.71View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/11/2013Brett P MoniaSVPSell9,375$23.76$222,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/30/2013Frederick T MutoDirectorSell10,000$21.96$219,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/16/2013Stanley T CrookeCEOSell1,460$14.00$20,440.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Ionis Pharmaceuticals (NASDAQ:IONS)
DateHeadline
07/21/16 04:50 PMWhat's Ionis Pharmaceuticals Inc Upside After Today's Huge Increase? - Press Telegraph
07/21/16 04:50 PMStock's Trend Analysis Report: Rackspace Hosting, Inc. (RAX), Ionis Pharmaceuticals, Inc. (IONS), Dollar General ... - iStreetWire
07/20/16 02:41 PMKKR & Co. L.P. (NYSE:KKR) & Ionis Pharmaceuticals (NASDAQ:IONS) Traders Recap - Money News (press release)
07/20/16 07:40 AMShares Positive Over the Past Month: Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - TGP
07/20/16 07:40 AMStocks inside Analysts Spotlight: Sophiris Bio, Inc. (NASDAQ:SPHS) , Ionis Pharmaceuticals Inc (NASDAQ:IONS) - Street Updates
07/19/16 04:45 PMIonis Pharmaceuticals Inc. Earns $10 Million From Janssen Biotech
07/19/16 04:45 PMCompany Update (NASDAQ:IONS): Ionis Pharmaceuticals Inc Licenses First Oral Antisense Drug Acting Locally in the ... - Smarter Analyst
07/19/16 10:46 AMIonis Pharmaceuticals Licenses First Oral Antisense Drug Acting Locally in the GI Tract to Janssen
07/18/16 04:50 PMIonis Pharmaceuticals (IONS) in Focus: Stock Soars 11.3% - Nasdaq
07/18/16 04:50 PMHot Stock under Consideration: Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - News Oracle
07/18/16 08:47 AMLarge call volume looks for surge in Ionis -
07/18/16 07:08 AMIonis Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : IONS-US : July 18, 2016 -
07/16/16 08:02 AMNoteworthy Friday Option Activity: PCLN, MDVN, IONS
07/15/16 03:43 PMIncreased Volatility Noted on Shares of: Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - Engelwood Daily
07/15/16 03:13 PMWhy Ionis Pharmaceuticals Inc. Is Surging Today - Sometimes no news is good news.
07/15/16 08:26 AMAnalysts Reviewing Stocks: CVS Health Corporation (NYSE:CVS) , Ionis Pharmaceuticals Inc (NASDAQ:IONS) - Street Updates
07/15/16 08:26 AMLeerink Swann Slashes Price Target for Ionis Pharmaceuticals Inc (IONS); Here's Why - Smarter Analyst
07/15/16 08:05 AMCoverage Initiated on Select Drug Manufacturer Stocks -
07/14/16 08:10 AMIsis Pharmaceuticals Inc.: Ionis Pharmaceuticals Announces Publication in ...
07/13/16 07:34 AMIonis Pharma (IONS) Announces Publication of Significant Antisense Technology Data - StreetInsider.com
07/13/16 07:34 AMHC Stocks in Action: Cytori Therapeutics Inc (NASDAQ:CYTX), Ionis Pharmaceuticals Inc (NASDAQ:IONS) - share market updates (press release)
07/13/16 07:34 AMHC Stocks in Hub: Ionis Pharmaceuticals Inc (NASDAQ:IONS), Medivation Inc (NASDAQ:MDVN) - share market updates (press release)
07/12/16 09:02 AMShares now down at $25.28 Ionis Pharmaceuticals Announces…
07/12/16 06:23 AMIonis Pharmaceuticals Announces Publication in Nature Biotechnology of a Novel Mechanism of Action for Antisense Drugs That Significantly Expands Therapeutic Opportunities - [at noodls] - CARLSBAD, Calif., July 12, 2016 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) today announced the publication of new research findings in Nature Biotechnology describing a new mechanism of ...
07/11/16 04:44 PMActive Watchful Movers- Legg Mason (NYSE:LM), Ionis Pharmaceuticals (NASDAQ:IONS), Sandstorm Gold (NYSEMKT ... - Seneca Globe
07/08/16 08:23 PMWhy Did Alnylam Pharmaceuticals’s Valuation Multiples Drop in 2016? -
07/07/16 07:32 AMIonis Pharma (IONS) Announces Positive Data from IONIS-TTRRx Phase 2, OLE Studies - StreetInsider.com
07/07/16 07:32 AMIncreased Volatility Watch for: Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - Engelwood Daily
07/07/16 06:01 AM7:01 am Ionis Pharma announces that results from phase 2 & phase 3 ongoing trials evaluating IONIS-TTR were presented at the XV International Symposium on Amyloidosis -
07/07/16 06:00 AMIonis Pharmaceuticals Reports Positive Clinical Data on IONIS-TTR Rx at the XV International Symposium on Amyloidosis - [PR Newswire] - In addition, new data from the ongoing open-label extension (OLE) study of IONIS-TTRRx in patients with familial amyloid polyneuropathy (FAP) who have completed dosing in the Phase 3 NEURO-TTR study presented in a poster at ISA on July 5 showed that both wild-type and mutant TTR levels were substantially reduced and that the reductions observed were approximately equal in magnitude regardless of the presence or location of the mutation.
07/06/16 09:20 AMIonis Pharmaceuticals Inc. (IONS) Has Broken Out Into Positive Territory
06/30/16 04:55 PMStocks Intraday Alert: Ionis Pharmaceuticals, Inc. (NASDAQ:IONS), Liberty Property Trust (NYSE:LPT) - Money News (press release)
06/29/16 07:30 AMIonis Pharmaceuticals Inc (NASDAQ:IONS)'s Company Shares Decreased 6.32% After High Volatility - Press Telegraph
06/28/16 09:35 AMHC Stocks Highlights: Ionis Pharmaceuticals Inc (NASDAQ:IONS), IDEXX Laboratories, Inc. (NASDAQ:IDXX) - share market updates (press release)
06/28/16 08:21 AMBetter Buy: NantKwest, Inc. vs. Ionis Pharmaceuticals -
06/27/16 04:40 PMIonis Pharma's (IONS) Akcea Therapeutics Announces Publication of Positive Volanesorsen Phase 2 Data
06/27/16 09:00 AMIonis Pharma's (IONS) Akcea Therapeutics Announces Publication of Positive Volanesorsen Phase 2 Data - StreetInsider.com
06/27/16 06:21 AMAkcea Announces Publication of Positive Volanesorsen Clinical Data Showing Reduced Triglycerides and Improved Insulin Sensitivity in Patients with High Triglycerides and Type 2 Diabetes - [at noodls] - CAMBRIDGE, Mass., June 27, 2016 /PRNewswire/ -- Akcea Therapeutics, a wholly owned subsidiary of Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) today announced the publication in Diabetes Care of positive ...
06/23/16 05:00 PMOrexigen Therapeutics, (NASDAQ:OREX) & Ionis Pharmaceuticals (NASDAQ:IONS) Healthcare Stocks on Trader's Radar - Wall Street 24
06/22/16 11:49 AMIonis Pharmaceuticals to Host R&D Day - [at noodls] - CARLSBAD, Calif., June 22, 2016 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) today announced that management will host an R&D Day on Wednesday, July 13 at 8:00 a.m. Eastern Time at The London ...
06/16/16 08:55 AMJim Cramer Tries To Limit Risk On Ionis Pharmaceuticals And Sarepta Therapeutics
06/15/16 04:42 PMValuable Analysts Trends to Observe: Johnson & Johnson (JNJ) , Ionis Pharmaceuticals (IONS) - Street Updates
06/15/16 04:42 PMPreview of Analysts Recommendation: St. Jude Medical, Inc. (NYSE:STJ) , Ionis Pharmaceuticals Inc (NASDAQ:IONS) - Street Updates
06/09/16 04:53 PMAnalysts Reviewing Stocks: Boston Scientific Corporation (NYSE:BSX) , Ionis Pharmaceuticals Inc (NASDAQ:IONS) - Street Updates
06/09/16 04:53 PMStock to Track: Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - News Oracle
06/09/16 04:53 PMIonis Pharmaceuticals (IONS): Today's Weak On High Volume Stock - TheStreet.com
06/09/16 07:22 AMMost Active Stocks Update: Las Vegas Sands Corp. (NYSE:LVS), Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - Beacon Chronicle
06/09/16 07:22 AMHC Stocks Updates: Ionis Pharmaceuticals Inc (NASDAQ:IONS), Dermira Inc (NASDAQ:DERM) - share market updates (press release)
06/08/16 04:56 PMWorthy Stock Update: Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - News Oracle
06/08/16 07:25 AMHC Stocks Midpoint: Ionis Pharmaceuticals Inc (NASDAQ:IONS), AstraZeneca plc (ADR) (NYSE:AZN) - share market updates (press release)

Social

About Ionis Pharmaceuticals

Ionis Pharmaceuticals logoIonis Pharmaceuticals, Inc., formerly Isis Pharmaceuticals, Inc., is a ribonucleic acid-targeted (RNA-targeted) drug discovery and development company. The Company is focused on discovering and developing antisense drugs. Its antisense drugs are used to treat a range of diseases, including cardiovascular; metabolic; severe and rare diseases, including neurological disorders, and cancer. Volanesorsen is a drug indicated to treat patients with high triglyceride levels, including patients with a genetic condition called familial chylomicronemia syndrome (FCS) and patients with partial lipodystrophy. It is focused on bringing its late-stage Phase III drugs, nusinersen, volanesorsen and IONIS-TTR to the market. Its lipid-lowering product, KYNAMRO (mipomersen sodium) injection, is on the market in the United States for patients with homozygous familial hypercholesterolemia (HoFH). Its products also include Alicaforsen, IONIS-DMPK-2.5, Plazomicin and IONIS-GCGR.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Other
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: IONS
  • CUSIP: 46433010
Key Metrics:
  • Previous Close: $28.38
  • 50 Day Moving Average: $23.97
  • 200 Day Moving Average: $35.03
  • P/E Ratio: N/A
  • P/E Growth: -0.46
  • Market Cap: $3.43B
  • Beta: 2.09
  • Current Year EPS Consensus Estimate: $-1.6 EPS
  • Next Year EPS Consensus Estimate: $-1.41 EPS
Additional Links:
Ionis Pharmaceuticals (NASDAQ:IONS) Chart for Tuesday, July, 26, 2016